SCHEMBL1781841

SCHEMBL1781841

CCC(C)c1ccc(CC(C)=COC)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
ALDH1A1 P00352 4/20 0.40
TSHR P16473 2/20 0.40
CYP2C9 P11712 1/20 0.40
HSP90AA1 P07900 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MAPT P10636 2/20 0.39
GAA P10253 2/20 0.39
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
ALOX12 P18054 1/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
USP2 O75604 1/20 0.36
PKM P14618 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1781840 1.00 NPC1 (0.41) NPC1RAB9AALDH1A1TSHRCYP2C9
SCHEMBL1785954 0.85 IDO1 (0.43) NPC1RAB9AALDH1A1L3MBTL1MAPT
SCHEMBL1785953 0.85 IDO1 (0.43) NPC1RAB9AALDH1A1L3MBTL1MAPT
SCHEMBL1782119 0.79 SMN1; SMN2 (0.39) NPC1RAB9AALDH1A1CYP2C9L3MBTL1
SCHEMBL1782120 0.79 SMN1; SMN2 (0.39) NPC1RAB9AALDH1A1CYP2C9L3MBTL1
SCHEMBL1785084 0.78 CXCR1 (0.41) TSHRCYP2C9LMNAESR1
SCHEMBL1785083 0.78 CXCR1 (0.41) TSHRCYP2C9LMNAESR1
SCHEMBL1781153 0.76 LPL (0.41) NPC1RAB9AALDH1A1L3MBTL1MAPT
SCHEMBL1781155 0.76 LPL (0.41) NPC1RAB9AALDH1A1L3MBTL1MAPT
SCHEMBL1782938 0.75 CTBP2 (0.38) NPC1RAB9AALDH1A1L3MBTL1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110118509-A1 NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS INTERNATIONAL FLAVORS & FRAGRANCES INC. 2011-05-19 US disclosed
US-20110118170-A1 NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS INTERNATIONAL FLAVORS & FRAGRANCES INC. 2011-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118509-A1 NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS TRPA1, OR51E2, CYP1B1 NPC1 1506/4885RAB9A 4804/4885ALDH1A1 186/4885
US-20110118170-A1 NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS TRPA1, OR51E2, CYP1B1 NPC1 1506/4885RAB9A 4804/4885ALDH1A1 186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.